Controlled Substances News & Updates
2023
2023 06/22- DEA Final Rule: Reporting Theft or Significant Loss Controlled Substances
2023 04/04- Temporary Placement of MDMB-4en-PINACA, 4F-MDMB-BUTICA, ADB-4en-PINACA, CUMYL-PEGACLONE, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I(link is external)
Past Articles
2022 April- DEA Requiring Online Submission Applications and Renewals
2022 April- Placement of Five Synthetic Cannabinoids in Schedule I
2022 July 27th- Withdrawal of proposed rule for placement as Schedule I the following: Placement of 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DiPT), 5-methoxy-alpha-methyltryptamine (5-MeO-AMT), 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT), 5-methoxy-N,N-diethyltryptamine (5-MeO-DET), and N,N-diisopropyltryptamine (DiPT)
2022 July 19th-Federal Registry Notice- Schedules of Controlled Substances: Removal of Fenfluramine From Control
2020 11-19 Holiday Closure and Ordering
2020 11-10 Controlled Substance Hours of Operation Update
2020 08-17 Controlled Substance Hours of Operation Update
2020 07-29 DEA - Federal Registration Notice
2020 07-28 DEA - Extortion Scam Targeting DEA Registrants
2020 04-30 Controlled Substance Hours of Operation Update
2020 04-15 DEA COVID-19 Information
2020 01-14 Buprenorphine Extended Release
